Laddar...

Insertional mutagenesis in a HER2-positive breast cancer model reveals ERAS as a driver of cancer and therapy resistance

Personalized medicine for cancer patients requires a deep understanding of the underlying genetics that drive cancer and the subsequent identification of predictive biomarkers. To discover new genes and pathways contributing to oncogenesis and therapy resistance in HER2+ breast cancer, we performed...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Oncogene
Huvudupphovsmän: Ikink, Gerjon J., Boer, Mandy, Bakker, Elvira R. M., Vendel-Zwaagstra, Annabel, Klijn, Chris, ten Hoeve, Jelle, Jonkers, Jos, Wessels, Lodewyk F., Hilkens, John
Materialtyp: Artigo
Språk:Inglês
Publicerad: Nature Publishing Group UK 2018
Ämnen:
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6168451/
https://ncbi.nlm.nih.gov/pubmed/29326437
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-017-0031-0
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!